Skip to content

CURAXIS PHARMACEUTICAL Corp

company.status.inactive

CIK 1434893fmd_10FCX5RR00DTN16H0M8V7DBH53Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Mar 31, 2012, 8 periods

Latest annual · FY2011

Millions
Operating income
(2)
Net income
1
Free cash flow
(1)

Latest quarter · Q1 FY2012

Millions
Operating income
(0)
Net income
(0)
Free cash flow
(0)
Open Financials

CURAXIS PHARMACEUTICAL Corp financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011FY2010ChangeSource
Operating income-$1.9 million-$1.9 million10-K 2012-03-29 · proof
Net income$1.3 million-$2.2 million10-K 2012-03-29 · proof
Cash from operating activities-$857,000-$1.3 million10-K 2012-03-29 · proof
Total assets$658,000$923,000-28.7%10-K 2012-03-29 · proof
Total liabilities$8.9 million$11.4 million-21.5%10-K 2012-03-29 · proof
Cash and cash equivalents$22,000$2,000+1,000%10-K 2012-03-29 · proof
What was CURAXIS PHARMACEUTICAL Corp's operating income in fiscal 2011?
CURAXIS PHARMACEUTICAL Corp reported operating income of -$1.9 million for fiscal 2011 (the year ended Dec 31, 2011), against -$1.9 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2012. SEC
What was CURAXIS PHARMACEUTICAL Corp's net income in fiscal 2011?
CURAXIS PHARMACEUTICAL Corp reported net income of $1.3 million for fiscal 2011 (the year ended Dec 31, 2011), against -$2.2 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2012. SEC
What was CURAXIS PHARMACEUTICAL Corp's cash from operating activities in fiscal 2011?
CURAXIS PHARMACEUTICAL Corp reported cash from operating activities of -$857,000 for fiscal 2011 (the year ended Dec 31, 2011), against -$1.3 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2012. SEC
What are CURAXIS PHARMACEUTICAL Corp's total assets?
As of Dec 31, 2011, CURAXIS PHARMACEUTICAL Corp reported total assets of $658,000, against $923,000 a year earlier (-28.7%). Source: the 10-K filed with the SEC on Mar 29, 2012. SEC
What are CURAXIS PHARMACEUTICAL Corp's total liabilities?
As of Dec 31, 2011, CURAXIS PHARMACEUTICAL Corp reported total liabilities of $8.9 million, against $11.4 million a year earlier (-21.5%). Source: the 10-K filed with the SEC on Mar 29, 2012. SEC
What are CURAXIS PHARMACEUTICAL Corp's cash and cash equivalents?
As of Dec 31, 2011, CURAXIS PHARMACEUTICAL Corp reported cash and cash equivalents of $22,000, against $2,000 a year earlier (+1,000%). Source: the 10-K filed with the SEC on Mar 29, 2012. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1434893&period_type=annual&limit=5"

Information only, not investment advice.